Skip to content

Public FDA record

Z-2497-2021: EVIS EXERA BF-XT160 Bronchofibervideoscope, Model No. BF-XT160

Recall record Z-2497-2021 for Olympus Corporation of the Americas. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2497-2021
Company in FDA record
Olympus Corporation of the Americas
FDA record creation date
Sep 21, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

A gluing step was not performed during the manufacturing of the affected device's insertion tube. There is a potential for the insertion tube to develop a leak, which poses an infection control risk.

Source facts

Action
On August 17, 2021, the firm issued Urgent Medical Device Correction letters to affected customers. Customers were informed that Olympus will repair your unit free of charge. An Olympus representative will contact you to make arrangements for return of your affected bronchoscope. If you have further questions about this recall, please contact laura.storms@olympus.com for additional information.
Initiated
2021-08-17
Root cause
Under Investigation by firm
Terminated
2024-01-12
Distribution
US Nationwide distribution in the states of CA, IL, MA, MD, MI, NY, OH, OR, and PA.
Recall number
Z-2497-2021
Recall status
Terminated
CDRH record ID
188993
FDA record created
2021-09-21
Recall event number
88560

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗